For the year ending 2025-12-27, PEP had $651M increase in cash & cash equivalents over the period. $7,672M in free cash flow.
| Cash Flow | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 8,295 | 9,626 | 9,155 | 8,978 |
| Depreciation and amortization | 3,451 | 3,160 | 2,948 | 2,763 |
| Gain associated with the juice transaction | - | 0 | 0 | 3,321 |
| Impairment and other charges | 1,946 | 714 | 1,230 | 3,618 |
| Indirect tax impact | - | 218 | - | - |
| Product recall-related impact | 0 | 187 | 136 | - |
| Payments for product recall-related impact | 6 | 148 | - | - |
| Operating lease right-of-use asset amortization | 727 | 655 | 570 | 517 |
| Share-based compensation expense | 288 | 362 | 380 | 343 |
| Restructuring charges | 983 | 727 | 445 | 411 |
| Cash payments for restructuring charges | 796 | 436 | 434 | 224 |
| Acquisition and divestiture-related charges | -453 | - | -41 | -80 |
| Payments for merger related costs | 228 | - | 41 | 46 |
| Pension and retiree medical plan expenses | 504 | 414 | 150 | 419 |
| Pension and retiree medical plan contributions | 472 | 348 | 410 | 384 |
| Deferred income taxes and other tax charges and credits | 71 | -42 | -271 | -873 |
| Tax expense related to the tcj act | - | 0 | 0 | 86 |
| Tax payments related to the tcj act | 772 | 579 | 309 | 309 |
| Accounts and notes receivable | 580 | 138 | 793 | 1,763 |
| Inventories | 150 | 314 | 261 | 1,142 |
| Prepaid expenses and other current assets | -195 | -40 | 13 | -118 |
| Accounts payable and other current liabilities | -677 | -1,161 | 420 | 1,842 |
| Income taxes payable | -433 | -123 | 310 | 57 |
| Other, net | -712 | -307 | 189 | -359 |
| Net cash provided by operating activities | 12,087 | 12,507 | 13,442 | 10,811 |
| Capital spending | 4,415 | 5,318 | 5,518 | 5,207 |
| Sales of property, plant and equipment | 528 | 342 | 198 | 251 |
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | 3,391 | 256 | 314 | 873 |
| Proceeds associated with the juice transaction | - | 0 | 0 | 3,456 |
| Divestitures, sales of investments in noncontrolled affiliates and other assets | 39 | 166 | 75 | 49 |
| More than three months - purchases | 190 | 425 | 555 | 291 |
| More than three months - maturities | 605 | 0 | 556 | 150 |
| More than three months - sales | 0 | 0 | 12 | - |
| Three months or less, net | -45 | -5 | -3 | -24 |
| Other investing, net | 100 | -14 | -48 | -11 |
| Net cash used for investing activities | -6,879 | -5,472 | -5,495 | -2,430 |
| Proceeds from issuances of long-term debt | 8,189 | 4,042 | 5,482 | 3,377 |
| Payments of long-term debt | 4,082 | 3,886 | 3,005 | 2,458 |
| Debt redemptions | - | 0 | 0 | -1,716 |
| More than three months - proceeds | 6,391 | 5,786 | 5,428 | 1,969 |
| More than three months - payments | 7,920 | 5,639 | 3,106 | 1,951 |
| Three months or less, net | 1,170 | 392 | -29 | -31 |
| Payments of acquisition-related contingent consideration | - | - | 0 | 0 |
| Cash dividends paid | 7,638 | 7,229 | 6,682 | 6,172 |
| Share repurchases - common | 1,000 | 1,000 | 1,000 | 1,500 |
| Proceeds from exercises of stock options | 97 | 166 | 116 | 138 |
| Withholding tax payments on restricted stock units (rsus) and performance stock units (psus) converted | 113 | 135 | 140 | 107 |
| Other financing | -73 | -53 | -73 | -72 |
| Net cash used for financing activities | -4,979 | -7,556 | -3,009 | -8,523 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 422 | -687 | -277 | -465 |
| Net increase/(decrease) in cash and cash equivalents and restricted cash | 651 | -1,208 | 4,661 | -607 |
| Cash and cash equivalents at beginning of period | 8,553 | 9,761 | 5,100 | 5,707 |
| Cash and cash equivalents at end of period | 9,204 | 8,553 | 9,761 | 5,100 |
PEPSICO INC (PEP)
PEPSICO INC (PEP)